Bio
Chandrayee Ghosh, PhD, is a Basic Life Research Scientist in the Department of Surgery at Stanford University School of Medicine and has been working in the field of Cancer and Immunology, with specific training and expertise in cancer therapeutics and translational science pertaining to drug repurposing and novel formulations of natural compounds. She has authored and coauthored 9 peer reviewed original articles in high impact journals. Her work has received media coverage both nationally and internationally. She presented her works in more than 18 international conferences and is recipient of research awards for her work. Her scientific contribution includes ground breaking findings such as identifying novel functions of FDA approved compounds and their combinations in targeting and assessing their mechanism of actions in one of the deadliest endocrine cancers anaplastic thyroid cancer, discovery of the interaction KDM3A with DCLK-1 and their role in pancreatic ductal adenocarcinoma tumorigenesis and stemness, identifying the cluster of master transcription factors or Super-Enhancers as novel targets for pancreatic cancer using novel formulation of natural compounds as anticancer agents.
Current Role at Stanford
Basic Life Research Scientist
